Literature DB >> 16716331

Determination of protein oxidation by mass spectrometry and method transfer to quality control.

Damian Houde1, Paivi Kauppinen, Rohin Mhatre, Yelena Lyubarskaya.   

Abstract

Characterization and quantitative analysis of oxidation plays an important role in biopharmaceutical development. This study demonstrates an approach to the assessment of susceptible to oxidation methionine residues in monoclonal antibodies and recombinant proteins. A method for the determination of oxidation levels by peptide mapping with mass spectrometric (MS) detection is described and its advantages compared to the UV detection are presented. Good linearity and reproducibility for determination of oxidation with MS detection are demonstrated (R2 > 0.99; RSDs of 4-9%). Aspects of method transfer to quality control group (QC) are discussed. As well, a quick and easy flow injection/MS method is proposed to substitute for peptide map analysis. Peptide coverage, linearity, reproducibility, robustness, sensitivity and quantitative oxidation results are compared for the flow injection/MS and LC/MS approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716331     DOI: 10.1016/j.chroma.2006.04.046

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  20 in total

1.  Characterization and sequence verification of thiolated deoxyoligonucleotides used for microarray construction.

Authors:  Arthur Van Aerschot; Jef Rozenski
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-08       Impact factor: 3.109

2.  Modifications of therapeutic proteins: challenges and prospects.

Authors:  Nigel Jenkins
Journal:  Cytotechnology       Date:  2007-05-25       Impact factor: 2.058

3.  Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies.

Authors:  Qing Xie; Benjamin Moore; Richard L Beardsley
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

4.  Post-translational modifications differentially affect IgG1 conformation and receptor binding.

Authors:  Damian Houde; Yucai Peng; Steven A Berkowitz; John R Engen
Journal:  Mol Cell Proteomics       Date:  2010-01-26       Impact factor: 5.911

5.  Expression vector-derived heterogeneity in a therapeutic IgG4 monoclonal antibody.

Authors:  Douglas S Rehder; Chris J Wisniewski; Denfeng Liu; Diya Ren; Dell Farnan; Matthew R Schenauer
Journal:  MAbs       Date:  2018-11-07       Impact factor: 5.857

6.  Effect of polysorbate 80 quality on photostability of a monoclonal antibody.

Authors:  Swita R Singh; Jingming Zhang; Courtney O'Dell; Ming-Ching Hsieh; Joel Goldstein; Joseph Liu; Arvind Srivastava
Journal:  AAPS PharmSciTech       Date:  2012-02-24       Impact factor: 3.246

Review 7.  A decade of proteomics studies of glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Proteomics Clin Appl       Date:  2014-02-16       Impact factor: 3.494

8.  Method for Quantifying Oxidized Methionines and Application to HIV-1 Env.

Authors:  Joshua T Shipman; Eden P Go; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2018-07-09       Impact factor: 3.109

9.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

10.  Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.

Authors:  Gülgün Tezel; Ivey L Thornton; Melissa G Tong; Cheng Luo; Xiangjun Yang; Jian Cai; David W Powell; Joern B Soltau; Jeffrey M Liebmann; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.